Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 19, 2020

Study Completion Date

May 20, 2022

Conditions
Chemotherapeutic Agent ToxicityCognitive/Functional EffectsLymphomaNeurotoxicityRadiation Toxicity
Interventions
BIOLOGICAL

Rituximab

One 28-day cycle = 500 mg/m\^2 intravenously on day 1 and day 5.

DRUG

Cytarabine

One 28-day cycle = 3 g/m\^2 intravenously on day 1 and day 2.

DRUG

Methotrexate

One 28-day cycle = 3.5 g/m\^2 intravenously (standard hydration/leucovorin support) on day 2.

DRUG

Procarbazine

One 28-day cycle = 100 mg/m\^2 orally on days 2-8.

DRUG

Vincristine

One 28-day cycle = 1.4 mg/m\^2 intravenously, dose capped at 2.4mg, on day 2 and day 16.

RADIATION

low-dose whole-brain radiation therapy

Total dose of 2340 cGy administered as 13 daily fractions of 180 cGy over 3 weeks. Participants with progressive disease on magnetic resonance imaging (MRI) do not receive WBRT.

Trial Locations (45)

10032

Columbia University Medical Center, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

11725

Memorial Sloan Kettering Cancer Center Commack, Commack

14642

University of Rochester, Rochester

17822

Geisinger Medical Center, Danville

18711

Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre

19103

American College of Radiology Imaging Network, Philadelphia

19107

Thomas Jefferson University Hospital, Philadelphia

21201

University of Maryland/Greenebaum Cancer Center, Baltimore

33612

Moffitt Cancer Center, Tampa

35233

University of Alabama at Birmingham Cancer Center, Birmingham

35243

The Kirklin Clinic at Acton Road, Birmingham

44106

Case Western Reserve University, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

45069

University Pointe, West Chester

45267

University of Cincinnati, Cincinnati

49007

West Michigan Cancer Center, Kalamazoo

53051

Community Memorial Hospital, Menomonee Falls

53188

Waukesha Memorial Hospital, Waukesha

53226

Froedtert and the Medical College of Wisconsin, Milwaukee

60153

Loyola University Medical Center, Maywood

60555

Cadence Cancer Center in Warrenville, Warrenville

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

77030

M D Anderson Cancer Center CCOP Research Base, Houston

M D Anderson Cancer Center, Houston

80907

Penrose-Saint Francis Healthcare, Colorado Springs

83706

Saint Alphonsus Cancer Care Center-Boise, Boise

85013

Saint Joseph's Hospital and Medical Center, Phoenix

85027

Arizona Oncology-Deer Valley Center, Phoenix

85260

Arizona Oncology Services Foundation, Scottsdale

89106

Nevada Cancer Research Foundation CCOP, Las Vegas

93720

Fresno Cancer Center, Fresno

94080

Kaiser Permanente Cancer Treatment Center, South San Francisco

94928

Rohnert Park Cancer Center, Rohnert Park

95051

Kaiser Permanente Medical Center - Santa Clara, Santa Clara

95670

Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova

95678

The Permanente Medical Group-Roseville Radiation Oncology, Roseville

95823

South Sacramento Cancer Center, Sacramento

04102

Maine Medical Center-Bramhall Campus, Portland

04074

Maine Medical Center- Scarborough Campus, Scarborough

48106-0995

Saint Joseph Mercy Hospital, Ann Arbor

03756

Dartmouth Hitchcock Medical Center, Lebanon

07920

Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NRG Oncology

OTHER

lead

Radiation Therapy Oncology Group

NETWORK

NCT01399372 - Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma | Biotech Hunter | Biotech Hunter